While you’re there, make sure to catch the presentation by Elke Ydens, Anju's Associate Director of Business Solutions. In the Clinical Data Management (CDM) and Patients Breakout stream (C5) on March 5 at 11:15 AM CET, Elke will show you how to meet your clinical trial diversity goals with smart trial design, from site identification to tracking and reporting.
Clinical trial stakeholders, from Regulatory Agencies to CROs and Pharmaceutical and Biotech companies, have recognized the need to make clinical trials more accessible to underserved populations. The DEPICT ACT in the US requires Diversity Action Plans to be in place that specify target enrollment broken down by race, ethnicity, age, and sex.
Starting with a smart trial design constitutes a critical part of the solution. Which sites can recruit specific patient populations? How can you continuously track actual enrollment rates per subgroup and targets per site? Which efficient ways of accessing and assessing the data can you implement? And how can you maximize insights on defined key metrics and indicators?
In this session, we discuss and demonstrate how technology can help to identify and select the right sites and investigators for your therapeutic area and we explore strategies for tracking and reporting on your patient diversity goals.
Consult the full conference program here.
- Credibility in the Fast Lane: Discover strategies to build credibility from the outset, ensuring a robust relationship between sponsors and CROs.
- Data-Driven Differentiation: Explore the power of data in reshaping the full-service CRO sales landscape. Learn how leveraging the right data can save time, streamline processes, and provide differentiation crucial for the RFP and Bid Defense process.
- Efficiency Through Insights: Gain insights into utilizing data to project realistic timelines, manage resource limitations, and ensure the delivery of high-quality outcomes.
- how technology can assist you with country/investigator selection
- how to gain a complete view of your trials from multiple data sources
- how to design a hybrid monitoring strategy
- how to reduce study set-up time
- and how to minimize cost and disruption during mid-study protocol amendments
- How to design a hybrid study
- How to reduce study set-up time
- How to better manage mid-study protocol amendments
- How to get SDTM data out
- Integration points
- this is test
This webinar on meeting diversity goals in clinical trials, co-hosted by Laura Acosta, Anju’s VP of Product Management, and Elke Ydens, our Associate Director of Business Solutions, explores how regulatory agencies, CROs, and industry leaders are striving to enhance accessibility to clinical trials for under served populations, aligned with the DEPICT ACT’s call for Diversity Action Plans. Discover innovative strategies and technology’s role in this pivotal mission. Watch recording here.
Our Anju hosts welcomed St. Jude Children’s Research Hospital’s Senior Manager-Clinical Research Systems from the Department of Cancer Center Administration Namratha Intha to talk about challenges with complex trials such as oncology, and how finding the right EDC solution can help you meet those challenges. Register here to view the webinar.
The right key opinion leader or KOL identification — with whom medical science liaisons (MSL) communicate and engage — can transform the effectiveness of the medical affairs and field medical teams. The MSL-KOL relationship can be crucial to successful patient outcomes.
Watch this webinar to learn how to move your MSL-KOL relationships from perfunctory to powerful. Join the featured speakers in reviewing the importance of KOL Identification and management and learn how to leverage the right technology and tools to create a quality engagement.
This webinar focuses on the various solutions needed for conducting decentralized clinical trials (DCTs)/hybrid clinical trials, including the interoperable technologies and partnerships required to provide the best patient experience.
Watch this webinar for ways to engage and retain patients and the factors to consider for implementing a successful end-to-end solution when evaluating or adopting technologies used in decentralized/hybrid clinical trials.
Watch our webinar to learn how artificial intelligence-assisted insights are helping medical affairs to measure outcomes, improve decision-making and reveal previously hidden impact insights.
During the conference Anju Senior Solutions Engineer, Medical Affairs Division, Steven Anzuini, presented a Hot Topic session titled “Managing Investigator and Internally Sponsored Publications”.
Anju Software has designed a compliant Approval Request solution within its Medical Affairs software, Pubstrat MAX. With Pubstrat MAX, anyone can easily submit a request to have their data or documents approved before sharing with internal teams or disclosing to the public. Anju’s Approval Request feature enables both internal and external stakeholders to answer a few questions, upload their document, and monitor the status of their request easily and compliantly.
Let’s talk about how a compliant request solution can help streamline your organization’s publication approval process.
On Wednesday, October 27th, Reed Mclaughlin and Kelly Malloy from Anju Software joined Donald L. Davis on the Life Science Success podcast. The discussion was centered around Reed and Kelly’s perspectives on the evolution of the Medical Affairs function, how it continues to emerge as a strategic pillar within life sciences organizations, and its critical importance to driving patient outcomes. They discussed how Anju Software medical affairs solutions like IRMS MAX and Pubstrat MAX are being leveraged to optimize work across medical affairs to increase effectiveness and leverage insights to ensure the right information is delivered to the right person at the right time.
The DIA Medical Information and Communications Conference is designed by medical information professionals for medical information professionals, building on a long series of very successful past editions. In this conference, we will leverage learnings on how to improve customers’ experience as they engage with pharma/biotech companies via various touchpoints. We will also explore when and how to successfully partner with suppliers.
Join Anju Software’s Global Customer Success Senior VP of Sales, Reed McLaughlin, and ProPharma Group’s Medical Information Supervisor, Americas, Stephanie Pruett and Medical Information Manager, Rachel Carlton for an Anju Software-sponsored on-demand session: Pre and Current COVID Medical Information Call Center World. The thought-provoking session, held on October 14 at 12:30 PM CET, looks at how a Medical Information Call Center adapts from a pre-COVID world to service their customer base during a global pandemic.
IRMS MAX, the gold standard of Medical Information solutions, offers unsurpassed capabilities, an intuitive user experience, and the ability to deliver the right information, to the right consumer, at the right time. Anju Software is leading the charge in assisting medical information practitioners adapt in a COVID world.
You don’t want to miss this insightful on-demand session. Click here to watch.
Innovation Theater: Utilizing Adaptive Technology Systems to Get the Most From Decentralized Trials
How can you navigate your own challenges in this evolving clinical trial environment? Learn how harnessing technology and data will help your transition from traditional trials to hybrid and decentralized trials. Kim Rejndrup presented jointly with Laura Acosta on “Utilizing Adaptive Technology Systems to Get the Most from Decentralized Trials” in the Innovation Theater. More specifically, this presentation sharing insights on:
Utilizing Adaptive Systems to Get the Most from Decentralized Trials
How can you navigate your own challenges in this evolving clinical trial environment? Learn how harnessing technology will help your transition from traditional trials to hybrid and decentralized trials. Kim Rejndrup, Senior Vice President of Product Development at Anju Software, presented on “Utilizing Adaptive Systems to Get the Most from Decentralized Trials”. This presentation sharing insights on: